Talon Therapeutics (TLON) FDA Approval & Other Updates

Talon Therapeutics, Inc. TLON

We are happy to report that TLON received its FDA stamp of approval today, and has been trading well as a result. A news release bearing the good news came across the wire this morning.

The high today was 1.23 after being as low as .86, for possible intraday gains of 43%

SOUTH SAN FRANCISCO, Calif., Aug 9, 2012 (GlobeNewswire via COMTEX) — Talon Therapeutics today announced Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies. This indication is based on overall response rate.

A conference call is slated to discuss this and other company developments is tomorrow:

Conference Call Information

 Date: August 10, 2012 
Time: 12:00pm EDT 
Dial-in (US and Canada):  (877) 681-1326  
Dial-in (International):  (708) 290-1158   
Webcast: www.talontx.com 


All American Pet Company, Inc. AAPT

A big-time performer off of this morning’s extended watchlist, AAPT has had a monster day thus far. After a close of .0129 yesterday, the daily range has been .015-.0224, for a total possible gain of 49.3%

We had this play in our watchlist originally beginning last week, giving our readers ample time to check out the stock. At the time, the low was .011, meaning anyone shrewd enough to jump on AAPT early this week, today enjoyed gains exceeding 100%


Extended Watchlist: